image
Healthcare - Medical - Devices - NASDAQ - US
$ 0.639
-3.91 %
$ 2.4 M
Market Cap
-0.5
P/E
CASH FLOW STATEMENT
-3.6 M OPERATING CASH FLOW
48.80%
-1 K INVESTING CASH FLOW
66.67%
4.22 M FINANCING CASH FLOW
101.82%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis NanoVibronix, Inc.
image
Net Income -3.71 M
Depreciation & Amortization 1 K
Capital Expenditures -1 K
Stock-Based Compensation 293 K
Change in Working Capital -322 K
Others 627 K
Free Cash Flow -3.6 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
OPERATING CASH FLOW
Net Income (3.7) (5.4) (14.3) (4.3) (5.8) (4.2) (5.0) (2.8) (2.9) (2.6) (2.0) (1.3) (0.7)
Depreciation & Amortization 1 K 1 K 2 K 2 K 4 K 6 K 5 K 7 K 9 K 9 K 10 K 9 K 10 K
Deferred Income Tax 0 0 8.5 (0.5) 0.6 0 0.5 0 1.0 0.1 77 K 0 0
Stock Based Compensation 0.3 0.4 0.4 0.4 1.8 0.9 0.8 0.5 0.2 24 K 0.5 28 K 63 K
Other Operating Activities 0.1 0.4 1.5 0.6 10 K 1.0 1.2 0.4 0.4 1.3 0.8 0.5 37 K
Change in Working Capital (0.3) (2.3) (0.5) 0.4 (0.4) (0.3) 0.2 0.4 (0.2) 0.3 39 K 43 K 66 K
Cash From Operations (3.6) (7.0) (4.4) (3.4) (3.9) (3.5) (2.2) (1.5) (1.5) (0.9) (0.6) (0.8) (0.5)
INVESTING CASH FLOW
Capital Expenditures 1 K 3 K 3 K 2 K 0 8 K 0 8 K 1 K 4 K 5 K 5 K 2 K
Other Items 0 0 0 0 0 0 0 0 0 0 0 0 0
Cash From Investing Activities 1 K 3 K 3 K 2 K 0 8 K 0 8 K 1 K 4 K 5 K 5 K 2 K
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0.4 0 0 0 0 0
Total Debt Repaid 0 0 0 42 K 0 0 1.4 0 0 0.9 0.6 0 1.0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 7 K 2 K 4.6 1 K 3.7 94 K 0 33 K 0 0 0 0 0.3
Cash From Financing Activities 4.2 2.1 4.6 9.5 4.3 94 K 6.4 33 K 3.0 0.9 0.6 0 1.3
CHANGE IN CASH
Net Change In Cash 0.6 (5.0) 0.2 6.2 0.4 (3.5) 4.3 (1.5) 1.5 4 K 7 K (0.8) 0.8
FREE CASH FLOW
Free Cash Flow (3.6) (7.0) (4.4) (3.4) (3.9) (3.6) (2.2) (1.5) (1.5) (0.9) (0.6) (0.8) (0.5)